Reports

Featured reports

National Drug Strategy Household Survey 2016: detailed findings 

This 2016 National Drug Strategy Household Survey report shows that: the decline in daily smoking slowed in 2016 but improvements were seen among people living in the lowest socioeconomic area; certain groups disproportionately experience drug-related risks and recent use of illicit drugs was particularly high for people who identified as homosexual or bisexual; just under 4 in 10 Australians either smoked daily, drank alcohol in ways that put them at risk of harm or used an illicit drug in the previous 12 months.

Non-medical use of pharmaceuticals: trends, harms and treatment 2006–07 to 2015–16 

The non-medical use of pharmaceuticals is common—about 1 million Australians (4.8%) aged 14 years or older reported recent non-medical use of a pharmaceutical drug. Prescriptions for opioid analgesics continued to increase and chronic pain and mental illness was higher among people with recent non-medical use of a pharmaceutical. Drug-induced deaths where benzodiazepines or other opioids like oxycodone and codeine were present, has more than doubled over the past decade.

National opioid pharmacotherapy statistics (NOPSAD) 2016 

On a snapshot day in 2016, almost 34,000 clients across 6 jurisdictions received pharmacotherapy treatment for their opioid dependence at 2,011 dosing points. There were 1,472 authorised prescribers of opioid pharmacotherapy drugs.

Data for Victoria and the Australian Capital Territory were unavailable at the time of the initial release on 29 March 2017. Additional supplementary tables were added on 14 November 2017 to include data for these jurisdictions as well as updated Australian totals.

Alcohol and other drug treatment services in Australia 2015–16 

In 2015–16, about 796 alcohol and other drug treatment services provided just over 206,600 treatment episodes to an estimated 134,000 clients. The top 4 drugs that led clients to seek treatment were alcohol (32% of treatment episodes), cannabis (23%), amphetamines (23%), and heroin (6%). The proportion of episodes where clients were receiving treatment for amphetamines has continued to rise over the 5 years to 2015–16, from 12% of treatment episodes in 2011–12 to 23% in 2015–16. The median age of clients in AOD treatment services is rising, from 31 in 2006–07 to 33 in 2015–16.

National Drug Strategy Household Survey (NDSHS) 2016—key findings  

This web-based release presents a summary of the national findings from the 2016 National Drug Strategy Household Survey. The 2016 NDSHS show that younger people (aged under 30) were smoking less, drinking less and using fewer illicit drugs in 2016 than in 2001. However, for people in their 40s, 50s and 60s, there was little to no change in drug usage behaviours over this period but their use of some drugs has increased between 2013 and 2016.

National opioid pharmacotherapy statistics 2014 

On a snapshot day in 2014, over 48,000 clients received pharmacotherapy treatment for their opioid dependence at 2,432 dosing points around Australia. As in previous year, methadone was the most common pharmacotherapy drug, with around two-thirds (67%) of clients treated with this drug. There were 2,319 prescribers of opioid pharmacotherapy drugs, an increase of 15% from 2013.

National Drug Strategy Household Survey detailed report: 2013 

This 2013 National Drug Strategy Household Survey report shows that: - fewer Australians are smoking daily and are smoking less cigarettes; - fewer people are exceeding the lifetime risk and single occasion risk guidelines for alcohol use; - overall illicit drug use has remained stable but some drugs have declined and some have increased; - alcohol continues to be the drug of most concern to the community but an increasing number of people are concerned about meth/amphetamines.

National Opioid Pharmacotherapy Statistics 2013 

On a snapshot day in 2013, over 47,000 clients received pharmacotherapy treatment for their opioid dependence at 2,355 dosing points around Australia. As in previous years, methadone was the most common pharmacotherapy drug, with around two-thirds (68%) of clients treated with this drug. There were 2,025 prescribers of opioid pharmacotherapy drugs, an increase of 15% from 2012.

The mental health of prison entrants in Australia: 2010 

This bulletin reports on the mental health of prison entrants, based on data from the 2010 National Prisoner Health Census. In 2010: - Nearly one third of prison entrants reported that they had mental health issues (a rate 2.5 times higher than the general population) - 16% of prison entrants took medication for mental health issues - 3 in 4 prison entrants who were taking mental health medication also used illicit drugs during the previous 12 months

Drugs in Australia 2010: tobacco, alcohol and other drugs 

Drugs in Australia 2010 provides a comprehensive summary of Australians' consumption of alcohol, tobacco and other drugs and use of treatment services, drawing on the latest statistics from major national collections. It also includes information about drug-related health issues, and drugs in the context of crime and law enforcement.

Measuring alcohol risk in the 2010 National Drug Strategy Household Survey: implementation of the 2009 Alcohol Guidelines 

This report outlines the steps involved to develop a consistent measure for analysing the 2010 National Drug Strategy Household Survey alcohol data. The report details the methods and questions used for reporting single occasion risk and lifetime risk in line with the National Health and Medical Research Council's Australian Guidelines to Reduce Health Risks from Drinking Alcohol. The development of these new guidelines impacted interpretation of the proportion of the population drinking alcohol at risky levels.

2010 National Drug Strategy Household Survey report 

This 2010 National Drug Strategy Household Survey report shows: positive and significant reductions since 2007 in daily tobacco smoking; mixed findings on alcohol consumption and risk; and a small overall rise in illicit drug use. In terms of attitudes to drugs, excessive alcohol use and tobacco smoking were nominated as the two most serious concerns to the community - and there were higher levels of support than previously for tobacco and alcohol harm reduction policies.

Reducing alcohol and other drug-related harm 

Rates of risky consumption of alcohol and other drugs among Indigenous Australians are generally twice those in the non-Indigenous population, and are both a consequence of - and contribute to - the gap in health and social well-being. This resource sheet discusses patterns of harmful use of alcohol and other drugs within Indigenous communities and evaluates the effectiveness of various intervention strategies. It outlines what works, what doesn't, and what further research is needed, regarding strategies concerning supply reduction, demand reduction, and harm reduction.

National Opioid Pharmacotherapy Statistics Annual Data (NOPSAD) 2010 collection: data guide 

The National Opioid Pharmacotherapy Statistics Annual Data (NOPSAD) 2010 data guide has been prepared as a reference for those involved in collecting and supplying data for the NOPSAD collection. This guide would be particularly useful to staff in Australian government, state and territory departments and researchers. This collection is one of a number of data sources that provide a picture of alcohol and other drug treatment services in Australia.

2007 National Drug Strategy Household Survey: detailed findings 

This report extends the analysis presented in the 2007 National Drug Strategy Household Survey: first results by providing more detailed information on drug use prevalence, drug-related behaviours and incidents, and support for drug-related policy and legislation. This report, along with others in the Drug Statistics Series, will be a useful resource for policy-makers, planners and researchers interested in drug-related matters.

2007 National Drug Strategy Household Survey: state and territory supplement 

This report presents data on patterns of drug use in each of the states and territories. It supplements the national findings from the '2007 National Drug Strategy Household Survey: first results' report, published in April 2008. The results are based on a survey of more than 23,000 Australians conducted in 2007, and provide profiles of drug use and community attitudes in each of the states and territories.

2007 National Drug Strategy Household Survey: first results 

2007 National Drug Strategy Household Survey: first results presents summary data collected in Australia's most comprehensive national survey of drug use and related issues. Comparisons with previous surveys are presented, along with population estimates of the numbers of consumers of tobacco, alcohol and illicit drugs. Key results on drug-related awareness, knowledge and behaviour are features of this report. This report is the 20th in the Australian Institute of Health and Welfare's Drug Statistics Series. Future reports in the series will cover extended analysis of the 2007 results and a comprehensive summary of major drug use statistical collections. This report and others in the series are useful resources for policy-makers, researchers and professionals interested in drug-related issues.

Statistics on drug use in Australia 2004 

This report is the eleventh in a series originally titled Statistics on Drug Abuse in Australia. The report provides a comprehensive summary of major drug use statistical collections, with references to sources of more detailed information. Data are presented on patterns of drug use (including trends and characteristics of substance users), international comparisons, drugs and health, special population groups, crime and law enforcement, polydrug use and drug avoidance and moderation. New to this edition is material presented on ecstasy and related drugs, patterns of substance use and psychological wellbeing, closed treatment episodes in alcohol and other drug treatment services, and females incarcerated in Australian prisons. This report and others in the Drug Statistics Series are useful resources for policy-makers, planners and researchers interested in drug-related matters.

2004 National Drug Strategy Household Survey: state and territory supplement 

This report presents data on patterns of drug use in each of the states and territories. It supplements the national findings from the '2004 National Drug Strategy Household Survey: first results' report, published in April 2005. The results are based on a survey of almost 30,000 Australians conducted in 2004, and provide profiles of drug use and policy support in each of the states and territories.

National comorbidity initiative: a review of data collections relating to people with coexisting substance use and mental health disorders 

Under Australia's National Illicit Drug Strategy, a National Comorbidity Initiative was established to improve service coordination and treatment outcomes for people with coexisting mental health and substance use disorders. A priority area under this Initiative is to improve data systems and collections methods within the mental health and alcohol and other drug sectors to manage comorbidity more effectively.This project, commissioned by the Australian Government Department of Health and Ageing, identifies, reviews and reports on the current state of data collections relating to people with coexisting substance use and mental health disorders ('comorbidity') in Australia.

2004 National Drug Strategy Household Survey: first results 

'2004 National Drug Strategy Household Survey: first results' presents summary data collected in Australia's most comprehensive national survey on drug issues. Key results on drug-related awareness, knowledge, attitudes and behaviour are features of this report. Comparisons with 1991, 1993, 1995, 1998 and 2001 surveys are presented and population estimates of the numbers of consumers of both licit and illicit substances are also provided. This report is the 13th in the Australian Institute of Health and Welfare's Drug statistics series. Future reports in the series will cover extended analysis of the 2004 results and a comprehensive summary of major drug use statistical collections. This report and others in the series are useful resources for policy makers, researchers and professionals interested in drug-related issues.